CTKB - CIK 0001831915
Cytek Biosciences, Inc. (CTKB) reported revenue of $201.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $201.49M | +0.5% |
| FY 2024 | $200.45M | +3.9% |
| FY 2023 | $193.01M | +6414.2% |
| FY 2022 | $2.96M | +35.9% |
| FY 2021 | $2.18M | +207.2% |
| FY 2020 | $710.00K | - |
Cytek Biosciences, Inc. (CTKB) reported revenue of $201.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Cytek Biosciences, Inc.'s revenue grew from $710.00K to $201.49M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.